Oncternal Therapeutics Inc (ONCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Sales | 646 | 622 | 1,827 | 687 | 344 |
| Cost of Goods | 223 | 185 | 920 | 245 | N/A |
| Gross Profit | 423 | 437 | 907 | 442 | 344 |
| Operating Expenses | 9,139 | 10,910 | 12,201 | 10,091 | 7,541 |
| Operating Income | -8,493 | -10,288 | -10,374 | -9,404 | -7,197 |
| Other Income | 697 | 345 | 354 | 324 | 314 |
| Pre-tax Income | -7,796 | -9,943 | -10,020 | -9,080 | -6,883 |
| Net Income Continuous | -7,796 | -9,943 | -10,020 | -9,080 | -6,883 |
| Net Income | $-7,796 | $-9,943 | $-10,020 | $-9,080 | $-6,883 |
| EPS Basic Total Ops | -335.90 | -559.83 | -573.83 | -517.84 | -643.81 |
| EPS Basic Continuous Ops | -336.41 | -564.20 | -568.57 | -515.23 | 213.20 |
| EPS Diluted Total Ops | -335.90 | -559.83 | -573.83 | -517.84 | -391.88 |
| EPS Diluted Continuous Ops | -336.41 | -564.20 | -568.57 | -515.23 | -389.66 |
| EBITDA(a) | $-8,538 | $-10,361 | $-10,459 | $-9,500 | $-7,376 |